This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q23.3 | Special Copayment Reduction: V147 (rare disease) |
| B. Synonyms | — |
| C. Adult onset | Likelihood of first presentation in adulthood low — most are diagnosed in childhood from a heart murmur or symptoms of heart failure. Mild cases may remain asymptomatic until adulthood and then be discovered, but this is rare. |
| 1. History | Before open-heart surgery only diagnosis was possible; surgical correction became possible from the 1950s; advances in valve repair techniques changed the prognosis. |
| 2. Causes | Various anatomical causes, including leaflet prolapse, chordal rupture, papillary muscle abnormalities, annular dilation, and leaflet cleft. |
| 3. Genetics | Marfan syndrome (FBN1), Ehlers-Danlos syndrome (COL5A1/A2), GATA4, etc.; mostly multifactorial inheritance. |
| 4. General epidemiology | About 0.5% of congenital heart malformations; rare, divided into forms associated with connective tissue disease and nonsyndromic forms. |
| 5. Pathophysiology | Incomplete valve closure → left ventricular volume overload → eccentric hypertrophy → diastolic dysfunction → reduced systolic function. |
| 6. Symptoms | Heart murmur in childhood, exercise intolerance, poor growth; with progression, dyspnea and palpitations; pulmonary edema in acute regurgitation. |
| 7. Signs | Systolic regurgitant murmur (apex to left axilla), hyperdynamic apical impulse, S3 on auscultation, left ventricular enlargement. |
| 8. Screening | Newborn auscultation; echocardiography in patients with connective tissue disease; follow-up of residual regurgitation after AVSD repair. |
| 9. Diagnosis | Echocardiography is the standard; quantification of regurgitation severity (vena contracta, EROA, RF); CMR for precise volumetric assessment. |
| 10. Treatment | Valve repair first (Carpentier technique); valve replacement if repair is not possible; emergency surgery for acute regurgitation after endocarditis. |
| 11. Prognosis | Good long-term prognosis with successful valve repair; reoperation rate 10–20%/10 years; surgery before EF decline determines prognosis. |
| 12. Prevention | Early diagnosis of connective tissue disease and echocardiographic follow-up; complete closure of the leaflet cleft during AVSD repair; timely surgery before EF decline. |
| 13. References | 10 major clinical guidelines and original papers |
Congenital mitral insufficiency (CMI) has a historical background similar to that of congenital mitral stenosis, and dysplastic mitral valve structures began to be described in autopsy studies from the late 19th century. However, in the era before echocardiography, it was difficult to clinically distinguish acquired regurgitation (rheumatic, ischemic) accurately from congenital regurgitation.
As open-heart surgery became possible in the 1950s–60s, surgery began to be attempted in patients with congenital mitral insufficiency. Initially, valve replacement was the main method, but because complications related to prosthetic valves in children (anticoagulation-related bleeding, limits of valve replacement with growth) were serious, attention focused on developing valve-preserving repair. With the establishment of Carpentier's pioneering mitral valve repair techniques (annuloplasty, leaflet resection, chordal reconstruction) in the 1980s, the rate of repair correction of congenital mitral insufficiency increased greatly.
Since the 1990s, advances in echocardiography have enabled detailed anatomical classification of mitral valve dysplasia, and on this basis surgical methods have become individualized. Currently, the standard strategy at pediatric cardiac centers is to attempt primary valve repair for most congenital mitral insufficiency and to consider valve replacement only when repair fails.
The anatomical causes of congenital mitral insufficiency are diverse, and Carpentier's functional classification (type I: normal motion, type II: excessive motion, type III: restricted motion) is widely used in surgical planning.
Cleft mitral valve: a malformation with a fissure in the middle portion of the anterior mitral leaflet, very common with atrioventricular septal defect (AVSD) and also occurring independently. Regurgitation occurs through the cleft during diastole.
Leaflet prolapse: a malformation in which a leaflet billows beyond the plane of the mitral annulus into the left atrium, occurring when the chordae are too long or there is excess valve tissue. It is often associated with connective tissue diseases such as Marfan syndrome and Ehlers-Danlos syndrome.
Chordal abnormalities: lack of valve support due to chordal rupture, chordal elongation, or absent chordae causes regurgitation. Congenitally, chordae that are too short restrict valve motion, and chordae that are too long cause prolapse.
Mitral annular dilation: when the annulus is excessively dilated, the relative area of the leaflets is insufficient, causing incomplete closure. Annular dilation also occurs secondary to left ventricular dilation.
Papillary muscle abnormalities: abnormal papillary muscle position or direct attachment to the valve (without chordae) restricts valve motion or causes regurgitation.
The genetic basis of congenital mitral insufficiency varies with the underlying cause.
Associated with connective tissue disease: Marfan syndrome (FBN1, 15q21.1 variants) reduces the elasticity of valve-supporting tissue through fibrillin-1 abnormalities, causing mitral valve prolapse and regurgitation. Mitral valve prolapse or regurgitation accompanies about 60–80% of patients with Marfan syndrome. In Ehlers-Danlos syndrome (COL5A1, COL5A2, COL3A1, etc.), mitral valve prolapse is also common because of connective tissue weakness. Mitral regurgitation has also been reported in Loeys-Dietz syndrome (TGFBR1/TGFBR2 variants).
Genes associated with leaflet cleft: GATA4 (8p23.1) variants cause atrioventricular septal defect together with leaflet cleft. NKX2.5 (5q35.1) variants are also associated with various valve malformations.
Nonsyndromic congenital mitral insufficiency: mostly multifactorial inheritance, and it is difficult to confirm a specific single gene. In cases with mitral valve prolapse alone, variants in MYH7, FLNA (filamin A), TPM1, and others have been reported.
Clinically, when connective tissue disease is suspected (tall body habitus, arachnodactyly, ectopia lentis, aortic dilation), specialist genetic counseling and testing of related genes are recommended. Genetic confirmation is important for family counseling and additional cardiovascular monitoring.
Congenital mitral insufficiency is rare, accounting for about 0.5% or less of all congenital heart malformations. Unlike acquired mitral regurgitation (degenerative, ischemic, rheumatic), it characteristically presents in childhood. However, mild cases may remain asymptomatic until adulthood and then be discovered.
It is broadly divided into forms associated with connective tissue disease (Marfan, Ehlers-Danlos, etc.) and nonsyndromic forms. In forms associated with connective tissue disease, systemic findings (skeletal, ocular, skin abnormalities) are present and aid diagnosis.
The leaflet cleft form is very common with atrioventricular septal defect (AVSD), and because AVSD is common in Down syndrome, congenital mitral insufficiency is also more common in patients with Down syndrome.
The incidence in males and females is generally equal, but for connective tissue diseases such as Marfan syndrome, sex differences vary by disease.
The core pathophysiology of congenital mitral insufficiency is left ventricular volume overload, in which the mitral valve fails to close completely during systole and left ventricular blood regurgitates into the left atrium. The regurgitant flow combines with normal pulmonary venous flow in the next diastole, leading to increased left ventricular filling (increased preload).
To adapt to the increased preload, the left ventricle develops eccentric hypertrophy. Initially, stroke volume increases by the Frank-Starling mechanism, maintaining compensation. During this period, the left ventricular ejection fraction (EF) may appear normal or above normal (pseudonormalization). If chronic volume overload persists, myocyte remodeling progresses and diastolic dysfunction develops. Eventually left ventricular systolic function also declines, with reduced EF and symptoms of heart failure.
Elevated left atrial pressure causes pulmonary venous hypertension and pulmonary edema. Left atrial enlargement induces atrial fibrillation, and atrial fibrillation worsens regurgitation, forming a vicious cycle. In acute severe regurgitation (chordal rupture, etc.), an abrupt rise in left atrial pressure and pulmonary edema occur without an adaptation period, creating an emergency.
The symptoms of congenital mitral insufficiency vary with the severity and rate of progression of regurgitation.
Mild to moderate: often found incidentally from a heart murmur in infancy to childhood. In mild cases, the patient may remain asymptomatic until adulthood. In moderate cases, dyspnea on exertion, easy fatigue, and reduced exercise capacity compared with peers occur. Poor growth may be present.
Severe: when left ventricular function declines, symptoms of heart failure such as dyspnea (especially on exertion), nocturnal orthopnea, fatigue, and lower-limb edema develop. With left atrial enlargement and atrial fibrillation, irregular heartbeat, palpitations, and pounding heart appear.
Acute severe regurgitation: when acute regurgitation occurs due to chordal rupture (spontaneous or after endocarditis) or papillary muscle dysfunction, an emergency arises with acute pulmonary edema, extreme dyspnea, cyanosis, and cardiogenic shock.
Associated with Marfan syndrome: because of systemic connective tissue abnormalities, systemic findings such as tall stature with long limbs, myopia, and lens dislocation are present. There is also a risk of aortic dissection.
Auscultation findings: a holosystolic regurgitant murmur radiating from the apex to the left axilla is characteristic. Care is needed because murmur intensity is not always proportional to regurgitation severity. In leaflet prolapse, the typical pattern is a late systolic murmur heard after a mid-systolic click. In severe regurgitation, a diastolic flow murmur may additionally be heard.
Palpation findings: because of left ventricular volume overload, the apical impulse is hyperdynamic and displaced laterally to the left. In severe cases, a thrill may be palpated at the apex.
Third heart sound (S3): in severe regurgitation, S3 is heard because of rapidly increased diastolic filling. S3 can appear with either left ventricular dysfunction or marked regurgitation.
ECG: left atrial enlargement (P mitrale), left ventricular hypertrophy (LVH), and atrial fibrillation are observed.
Chest X-ray: findings of left atrial enlargement (double density), left ventricular enlargement, and pulmonary venous congestion.
Universal screening of the general population is not performed.
Newborn auscultation screening: detection of a systolic murmur on auscultation immediately after birth is the main first clue. A holosystolic murmur requires echocardiography to distinguish it from other malformations such as VSD.
Echocardiography in patients with connective tissue disease: regular echocardiography (at least once a year) to evaluate mitral regurgitation is recommended in patients with confirmed Marfan syndrome, Ehlers-Danlos syndrome, and similar conditions. Even before genetic confirmation, echocardiography is performed when connective tissue disease is suspected from clinical findings (height, arachnodactyly, ectopia lentis, etc.).
Follow-up after AVSD repair: after surgical repair of atrioventricular septal defect, residual regurgitation commonly occurs even if the leaflet cleft was repaired, so regular postoperative follow-up echocardiography is essential.
Fetal echocardiography: fetal echocardiography is performed when left atrial enlargement or a mitral valve abnormality is suspected on prenatal ultrasound.
Echocardiography: the diagnostic standard. Color Doppler evaluates the direction and area of the regurgitant jet and the vena contracta width (≥7 mm = severe), and quantitative Doppler (EROA ≥0.4 cm² = severe, RF ≥50% = severe) quantifies severity. Two-dimensional echocardiography evaluates the type of leaflet motion (Carpentier classification), the presence of leaflet cleft, prolapse, or restricted motion, the number and position of papillary muscles, chordal status, and annular diameter. Left ventricular dilation (EDD >40 mm/m² BSA) and EF (EF <60%) are important in judging surgical indications.
Transesophageal echocardiography (TEE): used for detailed evaluation of valve anatomy, preoperative planning, and intraoperative assessment of results.
Cardiac MRI (CMR): useful for precise measurement of left ventricular volume and function, calculation of regurgitant fraction, and evaluation of patients with a poor echocardiographic window.
Cardiac catheterization: performed on a limited basis for direct measurement of pulmonary artery pressure and preoperative coronary artery evaluation.
Indications for intervention (based on the ACC/AHA 2020 guidelines): ① symptomatic severe regurgitation (Class I) ② asymptomatic severe regurgitation + EF ≤60% (Class I) ③ asymptomatic severe regurgitation + EDD >65 mm (Class IIa) ④ moderate to severe regurgitation when other cardiac surgery is performed (Class IIa).
Mitral valve repair: the first choice. Based on the Carpentier technique and according to the causative anatomy, procedures such as ① cleft repair ② annuloplasty ring ③ leaflet resection (quadrangular or triangular resection) ④ chordal replacement (Gore-Tex neochordae) ⑤ correction of leaflet prolapse (edge-to-edge repair, Alfieri stitch) are performed. The repair success rate differs by anatomical type, and cleft repair shows the best results.
Valve replacement: performed when repair is impossible or fails. In children, it is delayed as long as possible to maximize growth. A choice is made between mechanical valves (excellent durability, anticoagulation required) and bioprosthetic valves (no anticoagulation required, limited durability).
Acute severe regurgitation: acute regurgitation after chordal rupture or endocarditis requires emergency surgical correction.
The prognosis of congenital mitral insufficiency is determined by regurgitation severity, timing of surgery, and surgical method (repair vs. replacement).
Prognosis before surgery: in asymptomatic patients with mild to moderate regurgitation, the annual risk of symptom onset or left ventricular dysfunction is about 3–5%. Patients operated on while left ventricular function is preserved have a markedly better prognosis than those operated on after functional decline.
Prognosis after valve repair: with successful repair, 10-year survival is 85–95%, and the reoperation rate due to recurrent regurgitation is about 10–20%/10 years. Cleft repair shows the best long-term results, and reoperation rates are higher in complex anatomical types (such as those associated with parachute mitral valve).
Prognosis after valve replacement: in children, 10–15-year event-free survival after mechanical valve replacement is 75–85%, but valve-related complications (thrombosis, bleeding, hemolysis, valve disruption) and the need for re-replacement with growth are the main problems.
Associated with Marfan syndrome: because of accompanying aortopathy, aortic surgery is often additionally required besides the mitral regurgitation, making the prognosis more complex.
Primary prevention of congenital mitral insufficiency itself is not possible.
Early diagnosis of connective tissue disease: when connective tissue disease is suspected from clinical findings such as abnormal body habitus, ectopia lentis, and joint hypermobility, genetic testing and echocardiography are performed early to detect mitral regurgitation early.
Complete valve repair during AVSD surgery: During atrioventricular septal defect repair, complete suture closure of the leaflet cleft is attempted to minimize residual regurgitation. Incomplete closure is a major cause of reoperation.
Timely surgery: Surgery is performed while EF is in the normal range and left ventricular dilation is within acceptable limits, to prevent irreversible myocardial damage. Surgery after left ventricular dysfunction results in incomplete functional recovery.
Infective endocarditis prophylaxis: Prophylactic antibiotics before invasive procedures in high-risk patients with a dysplastic mitral valve.
Regular follow-up: Echocardiographic follow-up every 2–3 years for mild, every 1 year for moderate, and every 6 months for severe (asymptomatic) disease. In patients with associated connective tissue disease, aortic diameter is also monitored.
Pregnancy: Pregnancy in patients with severe regurgitation or left ventricular dysfunction is high risk, and surgical correction before pregnancy is recommended.
Carpentier A, Branchini B, Cour JC, et al. Congenital malformations of the mitral valve in children. J Thorac Cardiovasc Surg. 1976;72(6):854-866. PMID: 993139.
Stellin G, Padalino M, Milanesi O, et al. Surgical repair of congenital mitral valve malformations in infancy and childhood. J Heart Valve Dis. 2000;9(5):707-714. PMID: 11041205.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol. 2021;77(4):e25-e197. DOI: 10.1016/j.jacc.2020.11.018. PMID: 33342586.
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563-645. DOI: 10.1093/eurheartj/ehaa554. PMID: 32860028.
De Bonis M, Alfieri O. The edge-to-edge technique for mitral valve repair. J Heart Valve Dis. 2011;20(1):5-15. PMID: 21404841.
Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation. Eur J Echocardiogr. 2013;14(7):611-644. DOI: 10.1093/ehjci/jet105. PMID: 23733442.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for Adults with Congenital Heart Disease. J Am Coll Cardiol. 2008;52(23):e143-e263. DOI: 10.1016/j.jacc.2008.10.001. PMID: 19038677.
Roman MJ, Devereux RB, Kramer-Fox R, et al. Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. Am J Cardiol. 1989;63(5):317-321. DOI: 10.1016/0002-9149(89)90332-7. PMID: 2916579.
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900. DOI: 10.1016/S0735-1097(02)01886-7. PMID: 12084585.
Kalfa D, Butcher J, Bonhoeffer P, Yacoub M. Congenital mitral valve disease: from anatomy to treatment. Prog Pediatr Cardiol. 2012;33(1):45-56. DOI: 10.1016/j.ppedcard.2011.12.007.